Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value: $278M (100.0% shares, 0.0% debt)

Holdings (64)

XBI SPDR SERIES TRUST 8.1%
Value $22.55M Shares 100,000 Share Price $225.50 Est. Cost/Share — Unrealized @ Report Date —
ZBH ZIMMER HLDGS INC 4.2%
Value $11.75M Shares 100,000 Share Price $117.52 * Est. Cost/Share $94.02 Unrealized @ Report Date +11.0%
— ACTAVIS PLC 3.7%
Value $10.42M Shares 35,000 Share Price $297.63 Est. Cost/Share $262.80 Unrealized @ Report Date —
— ENDO HEALTH SOLUTIONS INC 2.9%
Value $8.073M Shares 90,000 Share Price $89.70 Est. Cost/Share $89.70 Unrealized @ Report Date —
CYH COMMUNITY HEALTH SYS INC NEW 2.8%
Value $7.842M Shares 150,000 Share Price $52.28 * Est. Cost/Share $41.41 Unrealized @ Report Date 0.0%
— NUVASIVE INC 2.6%
Value $7.358M Shares 160,000 Share Price $45.99 Est. Cost/Share $42.81 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 2.5%
Value $7.083M Shares 30,000 Share Price $236.10 * Est. Cost/Share $214.23 Unrealized @ Report Date -0.2%
— ZS PHARMA INC 2.5%
Value $6.943M Shares 165,000 Share Price $42.08 Est. Cost/Share $42.08 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 2.5%
Value $6.937M Shares 225,000 Share Price $30.83 Est. Cost/Share $25.00 Unrealized @ Report Date —
— CELGENE CORP 2.5%
Value $6.917M Shares 60,000 Share Price $115.28 Est. Cost/Share $115.28 Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 2.5%
Value $6.833M Shares 180,000 Share Price $37.96 Est. Cost/Share $27.98 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 2.2%
Value $6.028M Shares 120,000 Share Price $50.23 Est. Cost/Share $50.23 Unrealized @ Report Date —
— DYAX CORP 2.1%
Value $5.864M Shares 350,000 Share Price $16.75 Est. Cost/Share $14.25 Unrealized @ Report Date —
MMSI MERIT MED SYS INC 2.1%
Value $5.775M Shares 300,000 Share Price $19.25 * Est. Cost/Share $17.06 Unrealized @ Report Date +4.4%
MRK MERCK & CO INC NEW 2.1%
Value $5.748M Shares 100,000 Share Price $57.48 * Est. Cost/Share $40.30 Unrealized @ Report Date 0.0%
— WRIGHT MED GROUP INC 1.9%
Value $5.16M Shares 200,000 Share Price $25.80 Est. Cost/Share $26.87 Unrealized @ Report Date —
BDX BECTON DICKINSON & CO 1.8%
Value $5.026M Shares 35,000 Share Price $143.60 * Est. Cost/Share $118.55 Unrealized @ Report Date 0.0%
— GENOCEA BIOSCIENCES INC 1.8%
Value $4.981M Shares 420,000 Share Price $11.86 Est. Cost/Share $11.86 Unrealized @ Report Date —
— NUVASIVE INC 1.7%
Value $4.599M Shares 100,000 Share Price $45.99 Est. Cost/Share $42.81 Unrealized @ Report Date —
— ALCOBRA LTD 1.6%
Value $4.504M Shares 800,000 Share Price $5.63 Est. Cost/Share $5.63 Unrealized @ Report Date —
— AVALANCHE BIOTECHNOLOGIES IN 1.6%
Value $4.457M Shares 110,000 Share Price $40.52 Est. Cost/Share $46.08 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 1.6%
Value $4.362M Shares 35,000 Share Price $124.63 * Est. Cost/Share $83.16 Unrealized @ Report Date +27.4%
— SUNESIS PHARMACEUTICALS INC 1.5%
Value $4.288M Shares 1,750,000 Share Price $2.45 Est. Cost/Share $2.45 Unrealized @ Report Date —
— CEPHEID 1.5%
Value $4.268M Shares 75,000 Share Price $56.91 Est. Cost/Share $54.14 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 1.5%
Value $4.177M Shares 40,000 Share Price $104.42 * Est. Cost/Share $71.51 Unrealized @ Report Date +41.7%
A AGILENT TECHNOLOGIES INC 1.5%
Value $4.155M Shares 100,000 Share Price $41.55 Est. Cost/Share — Unrealized @ Report Date —
— REVANCE THERAPEUTICS INC 1.5%
Value $4.146M Shares 200,000 Share Price $20.73 Est. Cost/Share $20.73 Unrealized @ Report Date —
— GW PHARMACEUTICALS PLC 1.5%
Value $4.101M Shares 45,000 Share Price $91.13 Est. Cost/Share $91.13 Unrealized @ Report Date —
ABBV ABBVIE INC 1.5%
Value $4.098M Shares 70,000 Share Price $58.54 * Est. Cost/Share $38.85 Unrealized @ Report Date 0.0%
— AVALANCHE BIOTECHNOLOGIES IN 1.5%
Value $4.052M Shares 100,000 Share Price $40.52 Est. Cost/Share $46.08 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 1.4%
Value $3.911M Shares 120,000 Share Price $32.59 * Est. Cost/Share $34.37 Unrealized @ Report Date 0.0%
EXAS EXACT SCIENCES CORP 1.4%
Value $3.854M Shares 175,000 Share Price $22.02 * Est. Cost/Share $25.37 Unrealized @ Report Date 0.0%
FOLD AMICUS THERAPEUTICS INC 1.4%
Value $3.808M Shares 350,000 Share Price $10.88 * Est. Cost/Share $7.14 Unrealized @ Report Date +23.4%
— ACHILLION PHARMACEUTICALS IN 1.3%
Value $3.698M Shares 375,000 Share Price $9.86 Est. Cost/Share $9.86 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 1.3%
Value $3.651M Shares 60,000 Share Price $60.85 Est. Cost/Share $36.53 Unrealized @ Report Date +67.0%
— THERAPEUTICSMD INC 1.3%
Value $3.63M Shares 600,000 Share Price $6.05 Est. Cost/Share $5.07 Unrealized @ Report Date —
— BLUEBIRD BIO INC 1.3%
Value $3.623M Shares 30,000 Share Price $120.77 Est. Cost/Share $35.89 Unrealized @ Report Date —
— FLAMEL TECHNOLOGIES SA 1.3%
Value $3.596M Shares 200,000 Share Price $17.98 Est. Cost/Share $17.13 Unrealized @ Report Date —
INGN INOGEN INC 1.3%
Value $3.519M Shares 110,000 Share Price $31.99 Est. Cost/Share $32.28 Unrealized @ Report Date 0.0%
— VITAE PHARMACEUTICALS INC 1.3%
Value $3.513M Shares 300,000 Share Price $11.71 Est. Cost/Share $11.71 Unrealized @ Report Date —
— DBV TECHNOLOGIES S A 1.3%
Value $3.504M Shares 150,000 Share Price $23.36 Est. Cost/Share $25.37 Unrealized @ Report Date —
— NANOSTRING TECHNOLOGIES INC 1.2%
Value $3.414M Shares 335,000 Share Price $10.19 Est. Cost/Share $12.42 Unrealized @ Report Date —
— ENTELLUS MED INC 1.2%
Value $3.285M Shares 150,000 Share Price $21.90 Est. Cost/Share $21.90 Unrealized @ Report Date —
— RADIUS HEALTH INC 1.1%
Value $3.087M Shares 75,000 Share Price $41.16 Est. Cost/Share $41.16 Unrealized @ Report Date —
— DISCOVERY LABORATORIES INC N 1.1%
Value $2.975M Shares 2,500,000 Share Price $1.19 Est. Cost/Share $1.19 Unrealized @ Report Date —
— PERNIX THERAPEUTICS HLDGS IN 1.0%
Value $2.673M Shares 250,000 Share Price $10.69 Est. Cost/Share $10.69 Unrealized @ Report Date —
— IGNYTA INC 0.9%
Value $2.488M Shares 250,000 Share Price $9.95 Est. Cost/Share $9.95 Unrealized @ Report Date —
— LION BIOTECHNOLOGIES INC 0.9%
Value $2.422M Shares 200,000 Share Price $12.11 Est. Cost/Share $12.11 Unrealized @ Report Date —
— TETRAPHASE PHARMACEUTICALS I 0.9%
Value $2.382M Shares 65,000 Share Price $36.65 Est. Cost/Share $36.65 Unrealized @ Report Date —
— APPLIED GENETIC TECHNOL CORP 0.8%
Value $2.334M Shares 116,750 Share Price $19.99 Est. Cost/Share $19.99 Unrealized @ Report Date —
— FIVE PRIME THERAPEUTICS INC 0.8%
Value $2.285M Shares 100,000 Share Price $22.85 Est. Cost/Share $22.85 Unrealized @ Report Date —
— LOXO ONCOLOGY INC 0.8%
Value $2.179M Shares 175,000 Share Price $12.45 Est. Cost/Share $12.45 Unrealized @ Report Date —
— EPIZYME INC 0.8%
Value $2.16M Shares 115,000 Share Price $18.78 Est. Cost/Share $18.78 Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTL IN 0.8%
Value $2.1M Shares 200,000 Share Price $10.50 Est. Cost/Share $12.02 Unrealized @ Report Date —
— CELLADON CORP 0.7%
Value $1.894M Shares 100,000 Share Price $18.94 Est. Cost/Share $19.17 Unrealized @ Report Date —
— ADVAXIS INC 0.6%
Value $1.805M Shares 125,000 Share Price $14.44 Est. Cost/Share $8.01 Unrealized @ Report Date —
— UNILIFE CORP NEW 0.6%
Value $1.805M Shares 450,000 Share Price $4.01 Est. Cost/Share $4.01 Unrealized @ Report Date —
PODD INSULET CORP 0.6%
Value $1.668M Shares 50,000 Share Price $33.36 Est. Cost/Share $33.75 Unrealized @ Report Date 0.0%
— ASSEMBLY BIOSCIENCES INC 0.6%
Value $1.655M Shares 125,000 Share Price $13.24 Est. Cost/Share $10.61 Unrealized @ Report Date —
— KINDRED BIOSCIENCES INC 0.3%
Value $718K Shares 100,500 Share Price $7.14 Est. Cost/Share $7.14 Unrealized @ Report Date —
— BIOLASE INC 0.2%
Value $606K Shares 300,000 Share Price $2.02 Est. Cost/Share $2.41 Unrealized @ Report Date —
— OCERA THERAPEUTICS INC 0.2%
Value $589K Shares 125,000 Share Price $4.71 Est. Cost/Share $10.04 Unrealized @ Report Date —
GBIM GLOBEIMMUNE INC 0.2%
Value $506K Shares 68,973 Share Price $7.34 Est. Cost/Share $7.14 Unrealized @ Report Date +1.3%
— XOMA CORP DEL 0.1%
Value $262K Shares 72,000 Share Price $3.64 Est. Cost/Share $3.64 Unrealized @ Report Date —